Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.92 USD | +3.55% | -1.35% | +26.41% |
Chart calendar Oramed Pharmaceuticals Inc.
Past events on Oramed Pharmaceuticals Inc.
2023-07-13 09:00 am | Annual General Meeting |
2023-06-23 06:15 pm | American Diabetes Association Scientific Session |
2023-05-31 01:30 pm | Novel Therapies for Diabetes & Obesity Summit |
2023-05-10 | Q1 2023 Earnings Release |
2022-12-07 01:30 pm | Planet MicroCap Showcase |
2022-11-17 11:00 am | ORMD-0801 Phase 2 Trial Results Call |
2022-11-10 04:30 pm | Q3 2022 Earnings Release |
2022-09-13 03:00 pm | H.C. Wainwright Global Investment Conference |
2022-08-10 04:30 pm | Canaccord Growth Conference |
2022-06-30 09:00 am | Annual General Meeting |
2022-05-25 12:00 pm | H.C. Wainwright Global Life Sciences Investment Conference |
2022-03-30 12:00 pm | Investor Meeting - Key Opinion Leader |
2022-03-15 03:50 pm | Barclays Global Healthcare Conference |
2022-02-24 09:30 am | Aegis Capital Virtual Summit |
2022-01-04 | LifeSci Partners Corporate Access Event |
2021-11-24 | FY 2021 Earnings Release |
2021-11-18 11:00 am | Oravax Medical Inc and Genomma Lab 50/50 Joint Venture Agreement Call |
2021-11-15 11:30 am | H.C. Wainwright Israel Conference |
2021-09-30 12:00 pm | Cantor Fitzgerald Global Healthcare Conference |
2021-09-13 07:00 am | H.C. Wainwright Global Investment Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,70 2,70 0.22% | 2,71 3,96 -31.48% | 0,90 | 2,70 2,76 -2.24% | 1,34 1,32 1.52% | 1,30 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -14,6 -16,7 12.58% | -11,8 -16,9 30.42% | 0,00 | -40,6 -40,1 -1.13% | -15,8 -15,7 -0.15% | -20,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,1 -16,0 12.1% | -11,5 -11,9 3.53% | 0,00 | -37,7 -37,7 0.05% | 5,09 -10,2 149.86% | -11,3 |
Net income Million USD | Released Forecast Spread | -14,4 -15,8 9.23% | -11,5 -11,9 3.53% | 0,00 | -36,6 -37,1 1.39% | 5,53 -12,8 143.15% | -10,8 |
EPS USD | Released Forecast Spread | -0,82 -0,90 8.89% | -0,56 -0,58 4% | -0,31 | -0,94 -0,95 1.26% | 0,14 -0,32 144.44% | -0,26 |
Announcement Date | 27/11/19 | 24/11/20 | 30/03/22 | 06/03/23 | 06/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,67 0,70 -4.86% | 0,67 0,70 -3.71% | 0,68 0,69 -1.52% | 0,68 0,71 -4.64% | 0,67 0,73 -9.18% | 0,67 0,70 -3.71% | 0,00 0,70 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -11,3 -11,0 -2.29% | -11,4 -9,60 -18.93% | -8,19 -9,57 14.46% | -9,74 -9,98 2.4% | -5,21 -10,9 52.22% | -3,79 -4,67 18.76% | -2,89 -3,85 24.86% | -3,88 -3,85 -0.7% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,7 -10,8 0.85% | -11,1 -9,50 -16.49% | -7,15 -10,4 31.18% | -8,74 -10,00 12.6% | -3,61 -10,1 64.25% | -1,31 -4,00 67.18% | -3,28 -3,55 7.49% | 13,3 -2,00 764.8% |
Net income Million USD | Released Forecast Spread | -10,4 -10,8 3.47% | -10,5 -9,50 -10.87% | -7,06 -9,87 28.44% | -8,54 -9,48 9.87% | -3,40 -10,1 66.39% | -1,19 -3,93 69.64% | -3,22 -3,40 5.24% | 13,3 -4,80 377.83% |
EPS USD | Released Forecast Spread | -0,27 -0,27 0% | -0,27 -0,25 -10.2% | -0,18 -0,25 28.95% | -0,22 -0,24 7.69% | -0,08 -0,25 67.35% | -0,03 -0,10 70% | -0,08 -0,09 7.7% | 0,33 -0,12 375% |
Announcement Date | 12/05/22 | 10/08/22 | 10/11/22 | 06/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 06/03/24 |
Past sector events for Oramed Pharmaceuticals Inc.
2024-03-27 | SAB BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-27 | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release (Projected) |
2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
2024-03-27 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
2024-03-27 | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
2024-03-26 | AN2 THERAPEUTICS, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-26 | PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-26 04:01 pm | KORRO BIO, INC.: Q4 2023 Earnings Release |
2024-03-26 06:00 am | GYRE THERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Oramed Pharmaceuticals Inc. - Nasdaq
- Calendar Oramed Pharmaceuticals Inc.